Akums Drugs and Pharmaceuticals Limited (AKUMS) stock breaks out with a 5% intraday gain, clearing its 6-month resistance trendline..
Akums Drugs and Pharmaceuticals Limited (AKUMS) reports 13.9% YoY revenue growth in Q1 FY27, driven by strong CDMO performance.
Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS) stock price moves up by 5% intraday to ₹698.3, showing a bounce despite the 6M trendline status being in.
Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS) stock price moves up 5% intraday, clearing its 6-month resistance trendline. Current price: ₹692.85.
Akums Drugs and Pharmaceuticals Limited (AKUMS) reports Q4 FY26 results with 9.7% revenue growth and 61.6% EBITDA surge.